Lara Meisner - 02 Feb 2026 Form 4 Insider Report for Bicara Therapeutics Inc. (BCAX)

Role
Chief Legal Officer
Signature
/s/ Lara Meisner
Issuer symbol
BCAX
Transactions as of
02 Feb 2026
Net transactions value
$0
Form type
4
Filing time
04 Feb 2026, 16:34:05 UTC
Previous filing
01 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Meisner Lara Chief Legal Officer 116 HUNTINGTON AVENUE, SUITE 703, BOSTON /s/ Lara Meisner 04 Feb 2026 0001883986

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCAX Stock Option (Right to Buy) Award $0 +90,000 $0.000000 90,000 02 Feb 2026 Common Stock 90,000 $16.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in sixteen equal quarterly installments following February 2, 2026, subject to the Reporting Person's continued service on each such vesting date.